Signals presents insiders’ perspectives on the world of regenerative medicine and stem cell research, written by scientists and professionals in the field. It was launched as a partnership between two of Canada’s Networks of Centres of Excellence, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM). As of April 1, 2015, CCRM is now publishing Signals.
CCRM supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. A network of academics, industry and entrepreneurs, CCRM translates scientific discoveries into marketable products for patients.
Stem Cell Network
In pursuit of Canadian excellence and global leadership in applied stem cell research, the Stem Cell Network (2001-2015) supports multidisciplinary projects that translate research discoveries into new and better medical treatments.